On April 15, 2025, Rhinebeck Bancorp, Inc. (the “Company”), its wholly-owned subsidiary, Rhinebeck Bank (the “Bank”), and its mutual holding company, Rhinebeck Bancorp, MHC (the “MHC”), announced that Sharon McGinnis and Nancy K. Patzwahl have been appointed to the Board of Directors of the Company, the Bank and the MHC, effective April 15, 2025.
On April 15, 2025, Rhinebeck Bancorp, Inc. (the “Company”), its wholly-owned subsidiary, Rhinebeck Bank (the “Bank”), and its mutual holding company, Rhinebeck Bancorp, MHC (the “MHC”), announced that Sharon McGinnis and Nancy K. Patzwahl have been appointed to the Board of Directors of the Company, the Bank and the MHC, effective April 15, 2025.
Also on April 14, 2025, the Company appointed Daniel J. Rice IV, the Company’s Chief Executive Officer, as President and Interim Chief Financial Officer and Marc Horstman as Chief Operating Officer.
Also on April 14, 2025, the Company appointed Daniel J. Rice IV, the Company’s Chief Executive Officer, as President and Interim Chief Financial Officer and Marc Horstman as Chief Operating Officer.
On April 14, 2025, it was determined that Brian Allen and Akash Patel will no longer serve as President and Chief Operating Officer and Chief Financial Officer, respectively, of Net Power Inc. (the “Company”), effective as of April 15, 2025.
On April 14, 2025, it was determined that Brian Allen and Akash Patel will no longer serve as President and Chief Operating Officer and Chief Financial Officer, respectively, of Net Power Inc. (the “Company”), effective as of April 15, 2025.
Appointed
Ellen Conti
Chief Financial Officer and Treasurer
Sculptor Diversified Real Estate Income Trust, Inc.
Effective
2025-04-15
Filed
April 15, 2025, 7:59 PM ET
on April 15, 2025, the board of directors of the Company appointed Ellen Conti to serve as the Company’s Chief Financial Officer and Treasurer and as a member of its board of directors.
Departed
Herbert Alvin Pollard
Chief Financial Officer and Treasurer
Sculptor Diversified Real Estate Income Trust, Inc.
Effective
2025-04-11
Successor
Ellen Conti
Filed
April 15, 2025, 7:59 PM ET
On April 11, 2025, Herbert Alvin (“Hap”) Pollard notified the Company of his resignation as Chief Financial Officer and Treasurer and as a member of the board of directors of Sculptor Diversified Real Estate Income Trust, Inc.
Departed
Cindy Reiss-Clark
Senior Vice President and Chief Commercial Officer
On March 7, 2025, West Pharmaceutical Services, Inc. (the “Company”) announced that Cindy Reiss-Clark, former Senior Vice President and Chief Commercial Officer, departed from the Company effective that same date.
Appointed
Michael Stucky
Vice Chair of the Board
FNMA ·
FEDERAL NATIONAL MORTGAGE ASSOCIATION FANNIE MAE
Effective
2025-04-10
Filed
April 14, 2025, 7:59 PM ET
On April 10, 2025 and effective as of that date, Fannie Mae’s Board of Directors appointed Mr. Stucky to serve as Vice Chair of the Board.
Effective June 30, 2025, David D. Kaiser, our Chief Credit Officer, will be retiring and relinquishing all positions he holds with Arrow Financial Corporation (“Arrow”) and its subsidiaries.
Craig W. Best, President of the Corporation and Farmers and Merchants Trust Company of Chambersburg (the “Bank”), will succeed Timothy G. Henry as Chief Executive Officer of the Corporation and the Bank on April 29, 2025 upon conclusion of the Corporation’s 2025 Annual Meeting.
On April 8, 2025, Christopher Wright notified Roper Technologies, Inc. (the “Company”) of his intention to retire from the Company’s Board of Directors, effective as of the Company’s 2025 Annual Meeting of Shareholders to be held on June 10, 2025.
John Freund, M.D., a member of the Board of Directors (the “Board”) of Sutro Biopharma, Inc., a Delaware corporation (the “Company”) since 2014, informed the Board of his decision to not stand for re-election to the Board.
On April 12, 2025, Gavin D.K. Hattersley, President and Chief Executive Officer of Molson Coors Beverage Company (the “Company”) and a member of the Company’s Board of Directors (the “Board”), informed the Company and the Board that he intends to retire from the Company and as a member of the Board, in each case, by December 31, 2025.
Pursuant to notice provided on April 8, 2025, Charles Remsberg’s employment as the Chief Sales Officer of the Company will be terminated, effective May 30, 2025.
Effective April 14, 2025, the Board appointed David McIntyre as Chief Financial Officer, principal financial officer and principal accounting officer of the Company (the “Appointment”).
Effective April 11, 2025, Garth Lees-Rolfe resigned as Chief Financial Officer, principal financial officer and principal accounting officer of Inhibikase Therapeutics, Inc. (the “Company”).
the Company also announced its Board’s appointment of Sally A. Washlow as the Company’s new Chief Executive Officer, effective as of Mr. Jenkins’ Termination Date.
On April 13, 2025, Raghib Hussain, President, Products and Technologies of Marvell Technology, Inc. (“Marvell”), notified Marvell of his decision to resign from his position with Marvell effective as of May 2, 2025, to become the Chief Executive Officer of another company.
Appointed
Susan Roth Katzke
independent director
Blackstone Infrastructure Strategies L.P.
Effective
2025-04-11
Filed
April 14, 2025, 7:59 PM ET
On April 11, 2024, Blackstone Infrastructure Strategies Associates L.P., the general partner (the “General Partner”) of Blackstone Infrastructure Strategies L.P. (the “Fund”), and the Fund’s board of directors (the “Board”) appointed Susan Roth Katzke to the Board as an independent director.
Appointed
Armin Zerza
Executive Vice President and Chief Financial Officer
the Board appointed Denise W. Warren, current Chairman of the Board, as Interim Chief Executive Officer, to serve until the appointment of a new Chief Executive Officer of the Company.
The Board appointed Ms. Warren, Dawn L. Kussow, Executive Vice President and Chief Financial Officer of the Company, and Chad C. White, Executive Vice President, General Counsel and Secretary of the Company, to serve as members of the Office of the CEO (and designated each of Ms. Warren, Ms. Kussow and Mr. White as a principal executive officer of the Company), in each case, effective as of April 13, 2025.
The Board appointed Ms. Warren, Dawn L. Kussow, Executive Vice President and Chief Financial Officer of the Company, and Chad C. White, Executive Vice President, General Counsel and Secretary of the Company, to serve as members of the Office of the CEO (and designated each of Ms. Warren, Ms. Kussow and Mr. White as a principal executive officer of the Company), in each case, effective as of April 13, 2025.
Departed
Lucinda M. Baier
President and Chief Executive Officer and member of the Board
On April 14, 2025, the Company announced that the board of directors of the Company (the “Board”) and Lucinda M. Baier, the Company’s President and Chief Executive Officer and member of the Board, mutually agreed that Ms. Baier’s role serving as the Company’s President and Chief Executive Officer and as a member of the Board would cease, effective as of April 13, 2025.
On April 11, 2025, the Board of Directors (the “Board”) of Butler National Corporation (the “Company”) was increased in size from 6 director positions to 7 and Julie M. Bowen was appointed to fill the newly created vacancy.
Departed
Gavin Wood
Chief Financial Officer
Adaptimmune Therapeutics PLC
Effective
2025-08-31
Filed
April 14, 2025, 7:59 PM ET
Mr. Wood’s employment with Adaptimmune Limited will end on August 31, 2025 (the “Revised Termination Date”) by reason of redundancy.
Appointed
Barry E. Welch
Director
HASI ·
HA Sustainable Infrastructure Capital, Inc.
Effective
2025-04-15
Filed
April 14, 2025, 7:59 PM ET
On April 8, 2025, HA Sustainable Infrastructure Capital, Inc. (the “Company”) announced the election of Barry E. Welch and Laura A. Schulte to become a new independent directors of the Company’s Board of Directors (the “Board”) effective April 15, 2025.
Appointed
Laura A. Schulte
Director
HASI ·
HA Sustainable Infrastructure Capital, Inc.
Effective
2025-04-15
Filed
April 14, 2025, 7:59 PM ET
On April 8, 2025, HA Sustainable Infrastructure Capital, Inc. (the “Company”) announced the election of Barry E. Welch and Laura A. Schulte to become a new independent directors of the Company’s Board of Directors (the “Board”) effective April 15, 2025.
Richard Ziman, Chairman of the Board, will not stand for reelection at the 2025 annual meeting of stockholders (the “Annual Meeting”) as a result of Mr. Ziman’s decision to retire.
On April 10, 2025, Bruce Downey notified the Board of Directors (the “ Board ”) of C4 Therapeutics, Inc. (the “ Company ”) of his intention to retire from the Board and not to stand for reelection at the 2025 Annual Meeting of Stockholders.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.